Cargando…

A Multi-Domain Simulation Study of a Pulsatile-Flow Pump Device for Heart Failure With Preserved Ejection Fraction

Mechanical circulatory support (MCS) devices are currently under development to improve the physiology and hemodynamics of patients with heart failure with preserved ejection fraction (HFpEF). Most of these devices, however, are designed to provide continuous-flow support. While it has been shown th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozturk, Caglar, Rosalia, Luca, Roche, Ellen T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822361/ https://www.ncbi.nlm.nih.gov/pubmed/35145432 http://dx.doi.org/10.3389/fphys.2022.815787

Ejemplares similares

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

A Valveless Pulsatile Pump for Heart Failure with Preserved Ejection Fraction: Hemo- and Fluid Dynamic Feasibility
por: Escher, Andreas, et al.
Publicado: (2020)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Lakhani, Ishan, et al.
Publicado: (2019)

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
por: Dabiri, Yaghoub, et al.
Publicado: (2018)

Commentary: Heart Failure with Preserved Ejection Fraction Induces Beiging in Adipose Tissue
por: Chirumbolo, Salvatore
Publicado: (2016)

Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
por: Gevaert, Andreas B., et al.
Publicado: (2019)

Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
por: Cornuault, Lauriane, et al.
Publicado: (2022)

Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical research
por: Brette, Fabien, et al.
Publicado: (2022)

Remote Hind-Limb Ischemia Mechanism of Preserved Ejection Fraction During Heart Failure
por: Homme, Rubens P., et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction
por: Li, Hui, et al.
Publicado: (2022)

Quantification of Biventricular Strains in Heart Failure With Preserved Ejection Fraction Patient Using Hyperelastic Warping Method
por: Zou, Hua, et al.
Publicado: (2018)

Potential Role of the Retrotrapezoid Nucleus in Mediating Cardio-Respiratory Dysfunction in Heart Failure With Preserved Ejection Fraction
por: Toledo, Camilo, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Chirinos, Julio A., et al.
Publicado: (2019)

Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Chen, Zheng-Wei, et al.
Publicado: (2019)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex
por: Pickny, Lisa, et al.
Publicado: (2023)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
por: Nanayakkara, Shane, et al.
Publicado: (2022)

Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction
por: Huang, Wei-Ming, et al.
Publicado: (2019)

Disturbed Blood Flow Acutely Increases Endothelial Microparticles and Decreases Flow Mediated Dilation in Patients With Heart Failure With Reduced Ejection Fraction
por: Silva, Thiago O. C., et al.
Publicado: (2021)

Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study
por: Granegger, Marcus, et al.
Publicado: (2022)

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
por: van de Wouw, Jens, et al.
Publicado: (2019)

Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction
por: Prenner, Stuart B., et al.
Publicado: (2020)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Deciphering the Protein, Modular Connections and Precision Medicine for Heart Failure With Preserved Ejection Fraction and Hypertension Based on TMT Quantitative Proteomics and Molecular Docking
por: Zhou, Guofeng, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?
por: Ahmed, Talha
Publicado: (2020)

Paradoxical low-flow phenotype in hospitalized heart failure with preserved ejection fraction
por: Mele, Donato, et al.
Publicado: (2020)

High-Intensity Interval Training for Heart Failure Patients With Preserved Ejection Fraction (HIT-HF)-Rational and Design of a Prospective, Randomized, Controlled Trial
por: Gasser, Benedikt A., et al.
Publicado: (2021)

Hemodynamic Evaluation of a Centrifugal Left Atrial Decompression Pump for Heart Failure with Preserved Ejection Fraction
por: Abbasnezhad, Navideh, et al.
Publicado: (2023)

A Transgenic Mouse Model of Eccentric Left Ventricular Hypertrophy With Preserved Ejection Fraction Exhibits Alterations in the Autophagy-Lysosomal Pathway
por: Wenzel, Kristin, et al.
Publicado: (2021)

Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: an electromechanically detailed biophysical modeling study
por: Adeniran, Ismail, et al.
Publicado: (2015)

Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Egom, Emmanuel Eroume A.
Publicado: (2021)

Inhibition of peripheral chemoreceptors improves ventilatory efficiency during exercise in heart failure with preserved ejection fraction − a role of tonic activity and acute reflex response
por: Kulej-Lyko, Katarzyna, et al.
Publicado: (2022)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c5k7v19p2uamil6v4ql9ukapdf